🇺🇸 FDA
Patent

US 10844379

Conjugated antisense compounds and their use

granted A61KA61K31/7088A61K31/713

Quick answer

US patent 10844379 (Conjugated antisense compounds and their use) held by Ionis Pharmaceuticals, Inc. expires Mon Nov 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Ionis Pharmaceuticals, Inc.
Grant date
Tue Nov 24 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/7088, A61K31/713, A61K47/549, A61K47/59